NCT02971488View on ClinicalTrials.gov

The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID

CompletedOBSERVATIONAL
Enrollment

529

Participants

Timeline

Start Date

January 15, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

May 10, 2019

Conditions
Hepatitis CDrug UsersHarm ReductionHIV
Interventions
OTHER

Screening for HCV in PWID and Linkage-To-Care

"Screening, diagnosis and treatment of HCV in PWID, will be part of a harm reduction strategy.~Treatment of HCV infected PWID will be delivered in a multidisciplinary care setting with services to reduce the risk of reinfection and for management of the common social and psychiatric comorbidities in this population."

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

Fundacion SEIMC-GESIDA

OTHER

lead

Hospital Universitario Infanta Leonor

OTHER

NCT02971488 - The Impact on Linkage-to-care of an Alternative Hepatitis C Screening Method in PWID | Biotech Hunter | Biotech Hunter